Meridian gets FDA clearance for direct E coli test:
This article was originally published in Clinica
Meridian (US) has received FDA clearance for a new indication for its Premier EHEC test, allowing laboratories to detect E coli toxins directly from stool samples. This cuts 24 hours from the testing process since it had previously been necessary to culture organisms from stools of infected patients.
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.